BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18466985)

  • 1. The serotonin 5-HT7 receptor agonist LP-44 microinjected into the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2008 Aug; 191(2):184-9. PubMed ID: 18466985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of serotonin 5-HT(1B) receptor in the dorsal raphe nucleus affects REM sleep in the rat.
    Monti JM; Jantos H; Lagos P
    Behav Brain Res; 2010 Jan; 206(1):8-16. PubMed ID: 19737581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the serotonin 5-HT3 receptor in the dorsal raphe nucleus suppresses REM sleep in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 May; 32(4):940-7. PubMed ID: 18295951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the 5-HT(7) receptor antagonist SB-269970 microinjected into the dorsal raphe nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2006 Feb; 167(2):245-50. PubMed ID: 16290281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microinjection of the 5-HT7 receptor antagonist SB-269970 into the rat brainstem and basal forebrain: site-dependent effects on REM sleep.
    Monti JM; Leopoldo M; Jantos H; Lagos P
    Pharmacol Biochem Behav; 2012 Aug; 102(2):373-80. PubMed ID: 22659581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of the NMDA and AMPA/kainate receptors in the dorsal raphe nucleus prevents the 5-HT₃ receptor agonist m-chlorophenylbiguanide-induced suppression of REM sleep in the rat.
    Monti JM; Jantos H; Catenaccio V; Xavier S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1341-8. PubMed ID: 21514352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dorsal raphe nucleus administration of 5-HT1A receptor agonist and antagonists: effect on rapid eye movement sleep in the rat.
    Monti JM; Jantos H; Monti D; Alvariño F
    Sleep Res Online; 2000; 3(1):29-34. PubMed ID: 11382897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin control of sleep-wake behavior.
    Monti JM
    Sleep Med Rev; 2011 Aug; 15(4):269-81. PubMed ID: 21459634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic administration and local microinjection into the central nervous system of the 5-HT(7) receptor agonist LP-211 modify the sleep-wake cycle in the rat.
    Monti JM; Leopoldo M; Jantos H
    Behav Brain Res; 2014 Feb; 259():321-9. PubMed ID: 24286819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.
    Monti JM
    Sleep Med Rev; 2010 Oct; 14(5):319-27. PubMed ID: 20153670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of activation and blockade of 5-HT2A/2C receptors in the dorsal raphe nucleus on sleep and waking in the rat.
    Monti JM; Jantos H
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1189-95. PubMed ID: 16713054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of systemic and local microinjection into the central nervous system of the selective serotonin 5-HT6 receptor agonist WAY-208466 on sleep and wakefulness in the rat.
    Monti JM; Jantos H; Schechter LE
    Behav Brain Res; 2013 Jul; 249():65-74. PubMed ID: 23624323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking.
    Monti JM; Jantos H
    Prog Brain Res; 2008; 172():625-46. PubMed ID: 18772053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat.
    Monti JM; Jantos H
    Int J Neuropsychopharmacol; 2005 Mar; 8(1):75-86. PubMed ID: 15327697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased REM sleep after intra-dorsal raphe nucleus injection of flesinoxan or 8-OHDPAT: prevention with WAY 100635.
    Monti JM; Jantos H; Monti D
    Eur Neuropsychopharmacol; 2002 Feb; 12(1):47-55. PubMed ID: 11788240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective blockade of 5-hydroxytryptamine (5-HT)7 receptors enhances 5-HT transmission, antidepressant-like behavior, and rapid eye movement sleep suppression induced by citalopram in rodents.
    Bonaventure P; Kelly L; Aluisio L; Shelton J; Lord B; Galici R; Miller K; Atack J; Lovenberg TW; Dugovic C
    J Pharmacol Exp Ther; 2007 May; 321(2):690-8. PubMed ID: 17314195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism.
    Sakai K; Crochet S
    Eur J Neurosci; 2001 Jan; 13(1):103-12. PubMed ID: 11135008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of serotonin 5-HT7 receptor in regulating sleep and wakefulness.
    Monti JM; Jantos H
    Rev Neurosci; 2014; 25(3):429-37. PubMed ID: 24681431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.